These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35579794)

  • 1. Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children.
    Şimşek-Onat P; Hizarcioglu-Gulsen H; Ergen YM; Gumus E; Özen H; Demir H; Özen S; Saltık-Temizel İN
    Dig Dis Sci; 2023 Jan; 68(1):233-239. PubMed ID: 35579794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis.
    Fu W; Fu H; Ye W; Han Y; Liu X; Zhu S; Li H; Tang R; Wang Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108235. PubMed ID: 34678692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
    Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
    Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity.
    Acarturk G; Acay A; Demir K; Ulu MS; Ahsen A; Yuksel S
    Bratisl Lek Listy; 2015; 116(4):213-7. PubMed ID: 25773946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation.
    Aydemir Y; Pınar A; Hızal G; Demir H; Saltık Temizel IN; Özen H; Akbıyık F; Yüce A
    Int J Lab Hematol; 2017 Feb; 39(1):51-57. PubMed ID: 27808471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases.
    Roka K; Roma E; Stefanaki K; Panayotou I; Kopsidas G; Chouliaras G
    J Crohns Colitis; 2013 Nov; 7(10):797-802. PubMed ID: 23207168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study.
    Feng W; Liu Y; Zhu L; Xu L; Shen H
    BMC Gastroenterol; 2022 Nov; 22(1):485. PubMed ID: 36424535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity.
    Torun S; Tunc BD; Suvak B; Yildiz H; Tas A; Sayilir A; Ozderin YO; Beyazit Y; Kayacetin E
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):491-7. PubMed ID: 22841412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review.
    Langley BO; Guedry SE; Goldenberg JZ; Hanes DA; Beardsley JA; Ryan JJ
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children.
    Gupta SK; Fitzgerald JF; Croffie JM; Pfefferkorn MD; Molleston JP; Corkins MR
    Inflamm Bowel Dis; 2004 May; 10(3):240-4. PubMed ID: 15290918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
    Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
    J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
    Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
    Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
    Atia O; Shavit-Brunschwig Z; Mould DR; Stein R; Matar M; Aloi M; Ledder O; Focht G; Urlep D; Hyams J; Broide E; Weiss B; Levine J; Russell RK; Turner D
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):31-42. PubMed ID: 36306803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD).
    Benvenuti E; Pierini A; Gori E; Lucarelli C; Lubas G; Marchetti V
    Vet Sci; 2020 Sep; 7(3):. PubMed ID: 32971945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.